Publicaciones en las que colabora con RON GELLER - (14)

2023

  1. A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population

    Journal of Medical Virology, Vol. 95, Núm. 4

  2. A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status

    Journal of Medical Virology, Vol. 95, Núm. 1

  3. Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals

    Journal of medical virology, Vol. 95, Núm. 7, pp. e28900

  4. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant

    Journal of Medical Virology, Vol. 95, Núm. 1

  5. Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population

    The Journal of infection

2022

  1. Erratum: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation (PLoS Pathog (2022) 18:7 (e1010631) DOI: 10.1371/journal.ppat.1010631)

    PLoS Pathogens

  2. Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents

    Scientific reports, Vol. 12, Núm. 1, pp. 3788

  3. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection

    Journal of Medical Virology, Vol. 94, Núm. 9, pp. 4216-4223

  4. SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients

    Microorganisms, Vol. 10, Núm. 11

  5. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868

  6. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

    PLoS Pathogens, Vol. 18, Núm. 7 July

2021

  1. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 3, pp. 485-494

  2. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera

    Journal of Medical Virology, Vol. 93, Núm. 4, pp. 2301-2306

2020

  1. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

    Journal of Clinical Virology, Vol. 131